Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum, Severin
Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul 2003 - 2740-6 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
0732-183X
10.1200/JCO.2003.06.026 doi
Adult
Age Distribution
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Cyclophosphamide
Doxorubicin
Female
Follow-Up Studies
Germany
Humans
Intestinal Neoplasms--diagnosis
Lymphoma, B-Cell--diagnosis
Lymphoma, Non-Hodgkin--diagnosis
Lymphoma, T-Cell--diagnosis
Male
Middle Aged
Neoplasm Staging
Predictive Value of Tests
Prednisolone
Probability
Proportional Hazards Models
Prospective Studies
Radiotherapy, Adjuvant
Risk Assessment
Sex Distribution
Survival Analysis
Survival Rate
Treatment Outcome
Vincristine
Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul 2003 - 2740-6 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
0732-183X
10.1200/JCO.2003.06.026 doi
Adult
Age Distribution
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Cyclophosphamide
Doxorubicin
Female
Follow-Up Studies
Germany
Humans
Intestinal Neoplasms--diagnosis
Lymphoma, B-Cell--diagnosis
Lymphoma, Non-Hodgkin--diagnosis
Lymphoma, T-Cell--diagnosis
Male
Middle Aged
Neoplasm Staging
Predictive Value of Tests
Prednisolone
Probability
Proportional Hazards Models
Prospective Studies
Radiotherapy, Adjuvant
Risk Assessment
Sex Distribution
Survival Analysis
Survival Rate
Treatment Outcome
Vincristine